This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gamarra, F. Articles by Wehling, M. Search for Related Content PubMed PubMed Citation Articles by Gamarra, F. Articles by Wehling, M.

Impaired Rapid Mineralocorticoid Action on Free Intracellular Calcium in Pseudohypoaldosteronism¹

Institute of Clinical Pharmacology (M.W.), Faculty of Clinical Medicine at Mannheim, University of Heidelberg, Mannheim; Medizinische Klinik (F.G., R.M.H., A.U., P.C.S., M.W.), Klinikum Innenstadt, University of Munich, Munich; Universitätskinderklinik (G.S-S.), Abteilung für pädiatrische Endokrinologie, University of Essen, Essen; v-Hauner‘sche Kinderklinik (U.K.), University of Munich, Munich, Federal Republic of Germany

Address correspondence and requests for reprints to: Professor Martin Wehling, MD, Institute of Clinical Pharmacology, Faculty of Clinical Medicine at Mannheim, University of Heidelberg, Klinikum Mannheim, 68135 Mannheim, Federal Republic of Germany.

Earlier observations on impaired in vitro effects of aldosterone on lymphocytic sodium and potassium pointed to the involvement of a defective nongenomic rather than genomic effector in pseudohypoaldosteronism. In this study, we investigated nongenomic aldosterone action in five patients with pseudohypoaldosteronism with regard to a rapid increase of free intracellular calcium [Ca²⁺]_i in cultured nasal epithelial cells, assumably reflecting calcium influx through calcium channels. Patients were defined by episodes of salt loss despite high plasma aldosterone and renin levels. Four unaffected members of the families and four independent subjects served as controls. Considering an aldosterone-induced increase of [Ca²⁺]_i by at least 10 nm as positive response, only 12% of cells from patients were responsive compared with 25% in normal subjects (P < 0.05). In terms of absolute changes, mean increase of [Ca²⁺]_i was 1.6 ± 1.1 nm in the patients (range - 1–4) and 9.5 ± 2.7 nm (P < 0.025) in the controls (range 1–25). Basal [Ca²⁺]_i was not different between both groups (167 ± 5 vs. 169 ± 8 nm, mean ± SE).

These findings show an impaired nongenomic mineralocorticoid effector in patients with pseudohypoaldosteronism, which is in line with a defective sodium channel as shown recently by molecular cloning, and also with the fact that the classical, genomic intracellular receptor is structurally normal in these patients.

This article has been cited by other articles:

				J. W. Funder The Nongenomic Actions of Aldosterone Endocr. Rev., May 1, 2005; 26(3): 313 - 321. [Abstract] [Full Text] [PDF]